RECOGNITION
- Anaemia (WHO):
- Hb <130 g/L in males:
- Hb <120 g/L in non-pregnant females
- normal range for Hb includes patients who are anaemic
- look for cause
Symptoms
- Patients may tolerate a very low Hb levels
- do not base clinical decisions on Hb value alone
Severe
- Heart failure symptoms
- Chest pain
Moderate
- Shortness of breath at rest
- Palpitations
Mild
- Fatigue
- Shortness of breath on exertion
Assessment
Bleeding history
- Menstrual history
- Previous surgery
- Dental extraction
- Epistaxis, mucocutaneous bleeding symptoms
GI blood loss
- change in bowel habit, dyspepsia, melaena
Social history
- Diet: vegan/vegetarian, dietary content
- Medications
- Alcohol history
Medical history
- Coeliac disease
- Inflammatory bowel disease
- Anaemia/transfusion/iron
Family history
- Bleeding, anaemia, malignancy
Investigations
- FBC
- Serum Ferritin
- most reliably correlate with relative total body iron stores
INITIAL MANAGEMENT
Ferritin
- If infection/inflammation present, ferritin can be high with iron deficiency
- rheumatoid disease, liver disease, malignancy
- hyperthyroidism, kidney disease,
- heavy alcohol intake
- raised CRP/ESR
Ferritin < 15ng/mL
- Absolute iron deficiency
Ferritin 15-30 ng/mL
- Likely absolute iron deficiency
Ferritin 30-100 ng/mL with raised inflammatory markers/chronic inflammation
- Possible absolute iron deficiency
- Check transferrin saturations
- if < 20%, likely Iron deficiency
Normal/ raised Ferritin with infectious, inflammatory and malignant disease or CKD
- Potential functional iron deficiency due to iron restricted erythropoiesis
- In patients with CKD, review %HRC
Look for cause
On history and age/co-morbidities
- OGD/colonoscopy/CT colonoscopy
- Urinalysis for haematuria
- Anti-tTG Ab for coeliac (+IgA levels)
- Gynaecological review where appropriate
- Consider stool screening for parasites as per travel history
- Consider screening for H.Pylori
- Refer to haematologist if:
- No cause found
- IDA has recurred despite treatment or poor response to treatment
Usually unnecessary to further investigate
- Healthy young people with clear cause e.g. regular blood donors
- Menstruating young women with no history of GI symptoms or FHx colorectal cancer
- Pregnant women
- Terminally ill or unable to undergo invasive investigations
- When management would not be influenced by the results
- severe comorbidity
- potentially advanced age as discussed with the patient and carers
- Patients who refuse further investigations
TREATMENT
Oral iron
- Where time/history allows, prescribe elemental iron 100–200 mg oral daily
- ferrous sulphate (dried) 200mg daily
- ferrous fumarate 200mg daily
- ferrous gluconate 300mg daily
Administration
- To improve absorption, advise to take oral iron:
- with a source of vitamin C e.g. over-the-counter vitamin C tablet or orange juice
- away from other medications especially proton pump inhibitors and antacids
- away from tea and coffee as contain tannins that reduce absorption
- away from calcium including tablets and dietary sources
- Do not exceed maximum single dose
- Use concomitant laxatives where necessary
Stopping oral iron
- Unless haemoglobinopathy, continue oral iron for 3 months following normalisation of Hb/MCV/MCH
- to ensure iron stores replenished
Intolerance
- Change formulation, or
- Reduce dose and/or
- Use alternate day dosing
Intravenous iron (IVFe)
- Offer when oral iron is assessed as ineffective or inappropriate
- to avoid unnecessary red cell transfusion
- functional iron deficiency e.g. CKD, CCF
- In patients who are at particular risk of iron deficiency anaemia, consider an ongoing prophylactic dose
- Discuss with appropriate specialist
Administration
- Adhere to SOP/SPC
- Observe patients closely during and for 30 min after infusion for allergic reactions
- Ensure resuscitation facilities are available
- Anaphylaxis medications prescribed in advance
RBC transfusion in chronic anaemia
- Consider a single unit RBC transfusion in patients with:
- moderate/severe symptoms
- haemodynamically stable
- reversible cause of anaemia
- Hb <90 g/L
- Remember each unit transfused is a treatment decision
- See Chronic Anaemia: RBC transfusion
ASSESSING RESPONSE
Oral iron
- Review tolerance and compliance to oral iron at 1–2 weeks
- Consider checking reticulocyte count and FBC parameters at 7–10 days for patients on oral iron
IV iron
- Repeat FBC and ferritin at 4 weeks post IV iron to evaluate response
Response expected
- Hb should improve at approximately 10 g/L per week
- Lack of response is defined as an Hb increase <20 g/L after 2–4 weeks treatment
Long-term
- After iron stores replenished, monitor FBC every 3 months for 1 yr
- again at 1 yr or if symptoms of iron deficiency return
DISCHARGE
- Inform GP of:
- cause
- treatment
- monitoring required
© 2022 The Bedside Clinical Guidelines Partnership.
Created by University Hospital North Midlands and Keele University School of Computing and Mathematics.
Research and development team: James Mitchell, Ed de Quincey, Charles Pantin, Naveed Mustfa